Hide Assignment Information Turnitin This assignment will be submitted to Turnitin.

Hide Assignment Information

Turnitin™

This assignment will be submitted to Turnitin™.

Instructions

CTA Prototype Assignment

Weight: 20% of Final Grade

As discussed in class, in order for a clinical trial to be conducted in Canada, a Clinical Trial Application must be filed and approved by Health Canada before it can begin. As a regulatory affairs associate working for a large multinational pharmaceutical company, you have been asked to prepare a CTA for a new oncology product named “Sheridanumab”. The proposed study is for “An Open-label, Multicenter, Single-arm, Phase II Study of Sheridanumab in Patients with Germline BRCA1/2 Mutation and Platinum-sensitive Recurrent Ovarian Cancer”. You have previously held a pre-CTA meeting with Health Canada and have been given the green light to proceed with a CTA.

1. Create a prototype of your CTA, listing all relevant documents that you would need to file and what CTD section it would go in. If a CTA section does not apply, please indicate N/A. Please organize your Modules using the following tabular format:

CTD Module/Section

Document(s) you would provide in the section – if there are specific forms that need to be completed, please list which ones

1.1 Table of Contents

E.g. a table of contents for Modules 1-3

1.2.1 Drug Submission Application Form

1.2.2 Information on Prior-related applications

Etc.

2. Indicate what guidance document(s) you used to determine how to build your CTA prototype.

3. Summarize the differences between a CTA and IND.

General Instructions:
• The Prototype project should follow the APA format with font size 12 and 1.5 spacing, Times New Roman.
• Provide each question and your response following it. Include all references.
• A title page should be included in addition to the page limit. The title page should contain informtion such as Student Name, Student ID, Prototype title, course code etc.
• The marking rubric is atached for your reference.

image1.gif

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

1. Describe how course assignments or activities will help you Provide high-quality, safe, patient-centered care grounded in holistic health principles.

1. Describe how course assignments or activities will help you Provide high-quality, safe, patient-centered care grounded in holistic health principles. (Holistic Health & Patient-Centered Care) 2. Describe how course assignments or activities will help you achieve Integrate an understanding of nursing history in advancing psych nursing’s influence in health care. Talk

Neurotransmitter Table Neuro transmitter

Neurotransmitter Table Neuro transmitter Receptor Subtype Location/Function/Effects/symptoms of excess or deficit if applicable Distribution (ie: CNS/PNS, GI, vascular) Drug classes that target this neurotransmitter or receptor Specific medications that target this neurotransmitter or receptor Glutamate AMPA NMDA GABA GABA a GABA b Serotonin 5HT 5HT 1a 5HT 1B 5HT 1d

READ BELOW: 1. 1.  chose Atomoxetine for this patient.  2. List medication class and mechanism of action for the chosen medication. 1. According to Stahl

READ BELOW: 1. 1.  chose Atomoxetine for this patient.  2. List medication class and mechanism of action for the chosen medication. 1. According to Stahl (2021), this drug is a norepinephrine reuptake inhibitor and a selective norepinephrine inhibitor. Atomoxetine boosts norepinephrine/noradrenaline and increased dopamine in the prefrontal cortex. It also